SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

WVE - Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity

WVE